Skip to main content
OpenTrials
Completed

NCT Number: NCT02615119

Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa

This study aims to identify the brain regions responsible for encoding cardiorespiratory 'interoceptive' sensations and determine whether they are dysfunctional in individuals affected by eating disorders, anxiety, depression, or brain injury. By evaluating the same interoceptive sensations across different human illnesses, the investigators hope to provide convergent evidence resulting in identification of core underlying neural processes, and to discern relative contributions in each condition.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The human brain has constant access to a multitude of complex signals, which it must simplify and organize in order to sustain the integrity of the organism. Many of these signals originate from outside of the body, such as lights, sounds, and smells, and much is known about how humans consciously perceive these 'exteroceptive' signals and how the human brain represents them. Comparatively little is known about how the human brain processes 'interoceptive' signals originating from inside of the body, despite the fact that the brain has access to far more of them (for instance, intestinal tension, bladder distension, breath, heartbeat, body temperature, blood pressure, serum osmolality, inflammation, proprioception etc.).

The current study study therefore aims to identify the brain regions responsible for encoding cardiorespiratory 'interoceptive' sensations and determine whether they are dysfunctional in individuals affected by eating disorders, anxiety, depression, or brain injury. Participants in this study will receive stimulation of the cardiorespiratory channel of the interoceptive system using bolus intravenous infusions of isoproterenol, a peripherally acting medication similar to adrenaline, and saline. Stimulation will occur during functional magnetic resonance imaging (fMRI) as well as outside of the fMRI scanner. After the scan participants will consume a meal. By evaluating the same interoceptive sensations across different human illnesses, the investigators hope to provide convergent evidence resulting in identification of core underlying neural processes, and to discern relative contributions in each condition.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnostic and Statistical Manual 5 (DSM 5) criteria for anorexia nervosa and age 18 to 40, or generalized anxiety disorder, or panic disorder, or major depressive disorder, or brain injury caused either by herpes simplex encephalitis or Urbach-Wiethe disease.

Exclusion criteria

  • DSM 5 diagnosis with any of the following: Schizophrenia spectrum and other psychotic disorders, bipolar and related disorders, antisocial personality disorder, active suicidal ideation with intent or plan
  • Current cardiac arrhythmia
  • Current respiratory disease
  • Seizure disorder
  • MRI contraindications including: cardiac pacemaker, metal fragments in eyes/skin/body (shrapnel), aortic/aneurysm clips, prosthesis, by-pass surgery/coronary artery clips, hearing aid, heart valve replacement, shunt (ventricular or spinal), electrodes, metal plates/pins/screws/ wires, or neuro/bio-stimulators (TENS unit), persons who have ever been a professional metal worker/welder, history of eye surgery/eyes washed out because of metal, vision problems uncorrectable with lenses, inability to lie still on one's back for 60-120 minutes; prior neurosurgery; tattoos or cosmetic makeup with metal dyes, unwillingness to remove body piercings, and pregnancy.

Treatment and study plan

Isoproterenol

Drug

Intravenous infusions of isoproterenol, delivered in a randomized double blinded order, in each participant from each group. Participants will rate the experience of heartbeat and breathing sensations as well as anxiety induced by the infusion.

Other names: Isuprel

normal saline

Drug

Intravenous infusions of normal saline, delivered in a randomized double blinded order, in each participant from each group. Participants will rate the experience of heartbeat and breathing sensations as well as anxiety induced by the infusion.

Other names: Saline

Primary outcomes

  1. Change in cardiorespiratory sensation intensity

    Time frame: Baseline

    Visual analogue rating of intensity of heartbeat and breathing sensations (scale: 0 to 10) through study completion (e.g., the day of testing).

Secondary outcomes

  1. Change in anxiety level

    Time frame: Baseline

    Visual analog rating of level of anxiety (scale: 0 to 10) through study completion, an average of 2 weeks.

  2. Generalized anxiety disorder severity (Generalized Anxiety Disorder 7 scale)

    Time frame: Baseline

    7 questions on anxiety symptoms

  3. Panic disorder severity (Panic Disorder Severity scale)

    Time frame: Baseline

    panic symptoms questionnaire

  4. Major depressive disorder severity (Patient Health Questionnaire-9 scale)

    Time frame: Baseline

    9 questions on depression symptoms

  5. Eating disorder severity (Eating Disorder Examination scale)

    Time frame: Baseline

    questionnaire about eating disorder symptoms

Other outcomes

  1. Resting cardiac interoceptive sensitivity (heartbeat tapping task tap latencies (in milliseconds))

    Time frame: Baseline

    subject taps with their finger their own perceived heart beat

  2. Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic task of the valsalva maneuver

    Time frame: Baseline

    blood pressure assessed

  3. Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic handgrip task.

    Time frame: Baseline

    blood pressure assessed

  4. Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic task of mental arithmetic.

    Time frame: Baseline

    blood pressure assessed

  5. Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic cold pressor task.

    Time frame: Baseline

    blood pressure assessed

  6. Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic task of breath holding).

    Time frame: Baseline

    blood pressure assessed

  7. Structural magnetic resonance imaging (cortical thickness in millimeters cubed).

    Time frame: Baseline

    Structural MRI measure: cortical thickness.

  8. Functional magnetic resonance imaging (Blood Oxygenation Level Dependent i.e. BOLD signal)

    Time frame: Baseline

    Functional MRI measure: task based activation change

  9. EEG (coherence in alpha, beta, theta, delta, gamma frequencies, in Hertz (Hz))

    Time frame: Baseline

    EEG: global and local coherence.

  10. Change in heart rate

    Time frame: Baseline

    Average heart rate change versus pre-infusion baseline

  11. Change in breathing pattern

    Time frame: Baseline

    Average respiratory volume variability change versus pre-infusion baseline

Sponsors and collaborators

Lead sponsor

Laureate Institute for Brain Research, Inc.

Other

Collaborators

  • National Institute of Mental Health (NIMH)

Registry information

Important dates

Study start
2015
Primary completion
2023
Study completion
2023
First posted
Nov 26, 2015
Registry last updated
Nov 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.